ALS TDI Logo
Sign In
Donate
 Search
Press Room
The ALS Therapy Development Institute (ALS TDI) is the world's foremost drug discovery lab focused solely on ALS.
We are always looking to spread awareness about our work and ALS. Our brand information, logos, and media can be found below and are available for general use. Contact ALS TDI about press inquiries, please email marketing@als.net.
ALS TDI Resources
ALS TDI Logos
Use our logos to help promote your fundraisers. Please refer to our Style Guidelines document for correct usage.
ALS TDI Videos
Use videos from our lab to show who we are and help promote your fundraisers.
Style Guidelines
Please refer to our Style Guidelines document when creating assets with our logo and colors.
ALS TDI News
From trial readouts to news from our lab, you can find all of the latest ALS research news here.
Press Releases
View our official statements on information related to our research programs, clinical trial updates, community collaborations, and more.
This is your lab
ALS TDI Press Releases
Wednesday, August 13, 2025
United for Answers: Leading ALS Organizations Announce ‘Champion Insights’ to Unlock Why Athletes and Military Members Face Higher ALS Risk
The ALS Therapy Development Institute (ALS TDI) is proud to announce that it will lead all research operations for Champion Insights—a new study planned to launch this fall in partnership with Answer ALS and Augie’s Quest to Cure ALS. This effort aims to uncover critical genetic and metabolic factors that may help explain the significantly higher incidence of amyotrophic lateral sclerosis (ALS) among endurance athletes, military service members, and other potentially high-risk groups.
read more
Tuesday, June 24, 2025
ALS TDI Announces New Agreement with Axol Bioscience to Expand Access to ALS Patient iPSC-Derived Cells for Global Research
The ALS Therapy Development Institute (ALS TDI) is proud to announce that a collection of cells derived from ALS patient-derived induced pluripotent stem cell (iPSC) lines will now be made widely available to researchers around the world.
read more
Tuesday, March 18, 2025
ALS TDI Joins DataCite to Expand Access and Impact of ARC Dataset
The ALS Therapy Development Institute (ALS TDI) is pleased to announce its acceptance as a member of DataCite, a leading global organization dedicated to ensuring research is openly available and accessible across scientific disciplines. This partnership will significantly enhance the discoverability, accessibility, and citability of the ALS Research Collaborative (ARC) dataset, a vital resource in the global search for effective ALS treatments.
read more
A complete list of press releases from the ALS Therapy Development Institute.
More ALS TDI Press Releases
What Do I
Do Next?
Contact Us
Contact Us
About ALS TDI
About
ALS TDI